Revenue: The sum of all revenue fields included for a company's operating activities.
Rhythm Pharmaceuticals, Inc. (RYTM) had Revenue of $57.25M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$57.25M |
$-48.84M |
|
$4.80M |
|
$52.45M |
|
$104.32M |
|
$-47.06M |
|
$-0.47M |
|
$-47.54M |
|
$-47.54M |
|
$-47.51M |
|
$-47.51M |
|
$-47.51M |
|
$-47.51M |
|
$-47.06M |
|
$-46.79M |
|
64.98M |
|
64.98M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$466.92M |
|
$1.10M |
|
$13.28M |
|
$480.20M |
|
$105.94M |
|
-- |
|
$104.23M |
|
$210.17M |
|
$139.07M |
|
$264.71M |
|
$270.03M |
|
67.20M |
|
| Cash Flow Statement Financials | |
$-115.67M |
|
$-137.15M |
|
$217.96M |
|
$89.60M |
|
$54.82M |
|
$-34.78M |
|
$66.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.61% |
|
-82.20% |
|
-82.20% |
|
-- |
|
-83.03% |
|
-85.30% |
|
$-156.63M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.19 |
|
2.20 |
|
41.00 |
|
-34.16% |
|
-17.95% |
|
-9.89% |
|
-17.59% |
|
$4.02 |
|
$-2.41 |
|
$-1.78 |
|